Ticker AFMD – Affimed NV – sales, description, marketcap – Tickerday.com

AFMD

Affimed NV

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 316.31M; Volume: 88.62K; AvgVol 3m: 1.09M; Beta: 2.28;

Cost estimate:

P/E: –; EPS: -0.73; EPS growth quarter/prev quarter: 6.70%;

EPS growth this year: -56.50%; EPS growth past 5 years: ;

EPS ttm: -0.73;

P/S: 21.24; P/B: 06.05; P/Cashflow: 3.24; P/FCF: ;

Sales: 309.98K; Sales growth quarter/prev quarter: -27.50%; Sales growth past 5 years: 44.60%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -44.80%; ROE – return on equity: -134.00%; LT Debt/Equity: 0.01; Total Debt/Equity: 0.05;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 7.50%; Insider Transactions:0.00%;

Institutional Ownership: 54.20%; Institutional Transactions: 21.60%;

Data update: 07.10.2020.